HLTRF
Price
$3.80
Change
-$0.00 (-0.00%)
Updated
Aug 27 closing price
Capitalization
124.03M
LBTSF
Price
$13.36
Change
+$4.35 (+48.28%)
Updated
Jun 26 closing price
Capitalization
2.74B
Interact to see
Advertisement

HLTRF vs LBTSF

Header iconHLTRF vs LBTSF Comparison
Open Charts HLTRF vs LBTSFBanner chart's image
HLS Therapeutics
Price$3.80
Change-$0.00 (-0.00%)
Volume$100
Capitalization124.03M
Almirall SA
Price$13.36
Change+$4.35 (+48.28%)
Volume$332
Capitalization2.74B
HLTRF vs LBTSF Comparison Chart in %
Loading...
HLTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HLTRF vs. LBTSF commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HLTRF is a Buy and LBTSF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (HLTRF: $3.80 vs. LBTSF: $13.36)
Brand notoriety: HLTRF and LBTSF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HLTRF: 3% vs. LBTSF: 100%
Market capitalization -- HLTRF: $124.03M vs. LBTSF: $2.74B
HLTRF [@Pharmaceuticals: Generic] is valued at $124.03M. LBTSF’s [@Pharmaceuticals: Generic] market capitalization is $2.74B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HLTRF’s FA Score shows that 1 FA rating(s) are green whileLBTSF’s FA Score has 1 green FA rating(s).

  • HLTRF’s FA Score: 1 green, 4 red.
  • LBTSF’s FA Score: 1 green, 4 red.
According to our system of comparison, both HLTRF and LBTSF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HLTRF’s TA Score shows that 2 TA indicator(s) are bullish.

  • HLTRF’s TA Score: 2 bullish, 3 bearish.

Price Growth

HLTRF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while LBTSF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.10%. For the same industry, the average monthly price growth was +12.13%, and the average quarterly price growth was +87.01%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.10% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LBTSF($2.74B) has a higher market cap than HLTRF($124M). LBTSF YTD gains are higher at: 45.645 vs. HLTRF (41.264). LBTSF has higher annual earnings (EBITDA): 195M vs. HLTRF (15.5M). LBTSF has more cash in the bank: 323M vs. HLTRF (12.2M). HLTRF has less debt than LBTSF: HLTRF (55.6M) vs LBTSF (405M). LBTSF has higher revenues than HLTRF: LBTSF (1.05B) vs HLTRF (56.4M).
HLTRFLBTSFHLTRF / LBTSF
Capitalization124M2.74B5%
EBITDA15.5M195M8%
Gain YTD41.26445.64590%
P/E RatioN/A115.63-
Revenue56.4M1.05B5%
Total Cash12.2M323M4%
Total Debt55.6M405M14%
FUNDAMENTALS RATINGS
HLTRF vs LBTSF: Fundamental Ratings
HLTRF
LBTSF
OUTLOOK RATING
1..100
3343
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
31
Undervalued
PROFIT vs RISK RATING
1..100
10075
SMR RATING
1..100
9590
PRICE GROWTH RATING
1..100
4440
P/E GROWTH RATING
1..100
10087
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HLTRF's Valuation (26) in the null industry is in the same range as LBTSF (31). This means that HLTRF’s stock grew similarly to LBTSF’s over the last 12 months.

LBTSF's Profit vs Risk Rating (75) in the null industry is in the same range as HLTRF (100). This means that LBTSF’s stock grew similarly to HLTRF’s over the last 12 months.

LBTSF's SMR Rating (90) in the null industry is in the same range as HLTRF (95). This means that LBTSF’s stock grew similarly to HLTRF’s over the last 12 months.

LBTSF's Price Growth Rating (40) in the null industry is in the same range as HLTRF (44). This means that LBTSF’s stock grew similarly to HLTRF’s over the last 12 months.

LBTSF's P/E Growth Rating (87) in the null industry is in the same range as HLTRF (100). This means that LBTSF’s stock grew similarly to HLTRF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HLTRFLBTSF
RSI
ODDS (%)
Bearish Trend 1 day ago
52%
N/A
Stochastic
ODDS (%)
N/A
N/A
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
53%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
50%
Bullish Trend 1 day ago
13%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
47%
Bullish Trend 1 day ago
12%
Advances
ODDS (%)
Bullish Trend 19 days ago
50%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
57%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
49%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
HLTRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WEGRX12.37N/A
N/A
Allspring Emerging Growth R6
GAFSX19.92N/A
N/A
Gabelli Global Financial Services AAA
FLPSX45.91N/A
N/A
Fidelity Low-Priced Stock
ETGLX57.67N/A
N/A
Eventide Gilead N
RYTCX8.31-0.01
-0.12%
Royce Small-Cap Total Return Consult

HLTRF and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLTRF has been loosely correlated with LBTSF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if HLTRF jumps, then LBTSF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLTRF
1D Price
Change %
HLTRF100%
N/A
LBTSF - HLTRF
38%
Loosely correlated
N/A
INIS - HLTRF
17%
Poorly correlated
N/A
ETST - HLTRF
12%
Poorly correlated
-0.74%
HKMPF - HLTRF
11%
Poorly correlated
N/A
GTBIF - HLTRF
8%
Poorly correlated
+4.55%
More

LBTSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, LBTSF has been loosely correlated with HLTRF. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if LBTSF jumps, then HLTRF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LBTSF
1D Price
Change %
LBTSF100%
N/A
HLTRF - LBTSF
39%
Loosely correlated
N/A
ETON - LBTSF
30%
Poorly correlated
-1.12%
INDV - LBTSF
18%
Poorly correlated
+1.01%
IPSEY - LBTSF
15%
Poorly correlated
+3.39%
MEDXF - LBTSF
10%
Poorly correlated
N/A
More